EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome

Alessandro Ciavarella iD, Luciano Baronciani iD, Omid Seidizadeh iD, Paola Colpani iD, Elio Ingenito, Daniele Cattaneo iD, Maria Teresa Pagliari iD, Addolorata Truma iD, Alessandra Iurlo iD, Simona Maria Siboni iD, Flora Peyvandi iD

American Journal of Hematology · 2026-09 · 101 (9) · 2147-2156

DOI: 10.1002/ajh.70399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, online erschienen am 10.06.2026. Verfasst von Alessandro Ciavarella und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy. Hauptthemen laut MEDLINE: von Willebrand Diseases. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Italian Ministry of Health (Bando Ricerca Corrente), Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acquired von Willebrand Syndrome (AVWS) is a rare bleeding disorder characterized by quantitative or qualitative defects of von Willebrand factor (VWF) in patients without a personal or family history of bleeding. It is frequently associated with systemic diseases, particularly lymphoproliferative disorders (LPDs) and myeloproliferative neoplasms (MPNs). In this single‐center, retrospective cross‐sectional study, we included patients diagnosed with AVWS at the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center between April 2014 and March 2025. Bleeding severity was assessed using the ISTH‐BAT score. Laboratory tests included FVIII:C, VWF:Ag, VWF:GPIbR, VWF:RCo, VWF:CB, VWFpp, and multimer analysis. Among 140 patients, 106 (76%) had MPNs and 26 (19%) LPDs. At least one bleeding symptom was observed in 70% of patients, with clinically significant bleeding occurring in 24% of the cohort. Clinically relevant bleeding (mainly mucocutaneous and gastrointestinal) was more frequent and severe in LPDs (58%) than in MPNs (13%). LPDs showed severe VWF functional defects, marked HMWM loss, and elevated VWFpp/VWF:Ag ratios (median 6.7), consistent with accelerated clearance. MPNs displayed mild HMWM reduction, normal clearance (median VWFpp/VWF:Ag ratio 1.0), and an inverse correlation between platelet count and the degree of HMWM depletion (ρ = −0.48, p < 0.001). Bleeding severity correlated inversely with VWF:GPIbR in LPDs (ρ = −0.50, p = 0.02) and with VWF:RCo in MPNs. Anti‐VWF antibodies were found in 30% of tested LPDs or autoimmune cases. The two main phenotypes presented in AVWS were immune‐mediated in LPDs and platelet‐mediated in MPNs. Understanding the underlying mechanism is crucial for accurate diagnosis and targeted treatment to reduce bleeding risk and improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand DiseasesHumansFemaleMalevon Willebrand FactorRetrospective StudiesCross-Sectional StudiesMiddle AgedAdultAgedHemorrhageMyeloproliferative DisordersLymphoproliferative DisordersAged, 80 and over

Stichwörter der Autor:innen

acquired blood coagulation disordershemorrhagelymphoproliferative disordersmyeloproliferative neoplasmsvon Willebrand diseasevon Willebrand factor

Substanzen

von Willebrand Factor

Autor:innen und Institutionen

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
  • Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

ORCID-Profile: Alessandro Ciavarella, Luciano Baronciani, Omid Seidizadeh, Paola Colpani, Daniele Cattaneo, Maria Teresa Pagliari, Addolorata Truma, Alessandra Iurlo, Simona Maria Siboni, Flora Peyvandi

Förderung

  • Italian Ministry of Health (Bando Ricerca Corrente)
  • Ministero della Salute

Zitieren

APA

Ciavarella, A., Baronciani, L., Seidizadeh, O., Colpani, P., Ingenito, E., Cattaneo, D., Pagliari, M. T., Truma, A., Iurlo, A., Siboni, S. M., & Peyvandi, F. (2026). Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome. American Journal of Hematology, 101(9), 2147-2156. https://doi.org/10.1002/ajh.70399

Vancouver

Ciavarella A, Baronciani L, Seidizadeh O, Colpani P, Ingenito E, Cattaneo D, et al. Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome. American Journal of Hematology. 2026;101(9):2147-2156. doi:10.1002/ajh.70399

BibTeX
@article{Ciavarella2026,
  author = {Ciavarella, Alessandro and Baronciani, Luciano and Seidizadeh, Omid and Colpani, Paola and Ingenito, Elio and Cattaneo, Daniele and Pagliari, Maria Teresa and Truma, Addolorata and Iurlo, Alessandra and Siboni, Simona Maria and Peyvandi, Flora},
  title = {Clinical and Laboratory Characterization of Acquired Von Willebrand Syndrome},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {9},
  pages = {2147--2156},
  doi = {10.1002/ajh.70399}
}
Kostenlos starten →